August 2026
Ireland is once again at the centre of an important international discussion on assisted reproduction. The proposed Health (Assisted Human Reproduction) (Amendment) Bill 2026 seeks to resolve legal uncertainties surrounding children born through donor-assisted reproduction and surrogacy abroad, while addressing gaps that remained after the Health (Assisted Human Reproduction) Act 2024 was passed.
At a first glance, the proposed amendments appear primarily administrative recognising parentage, clarifying citizenship and implementing outstanding provisions. However, they raise much broader questions that many countries are currently facing:
• How should societies regulate increasingly international fertility treatment or Cross Border Reprodutive Care (CBRC)?
• How can legislation protect children without unintentionally disadvantaging families?
• Where should governments draw the line between ethical safeguards and practical realities?
Why is another amendment necessary?
Although Ireland adopted comprehensive assisted reproduction legislation in 2024, significant parts of the Act have not yet been commenced. One of the biggest challenges concerns children born through donor-assisted reproduction or surrogacy outside Ireland. Increasing numbers of Irish residents travel abroad because treatments such as donor conception or surrogacy are either unavailable, more accessible, or legally clearer elsewhere.
Unfortunately, when they return home, recognition of legal parentage and, in some cases, citizenship has not always been straightforward. The proposed Amendment Bill aims to provide a legal pathway to recognise these families while also making a number of technical improvements to the 2024 legislation.
The advantages of the proposal
Greater legal certainty for children
Perhaps the strongest argument in favour of the amendments is that children should never suffer legal uncertainty because of the circumstances surrounding their conception or birth. The Bill seeks to ensure that children born through donor-assisted reproduction or surrogacy abroad can obtain legal recognition of their intended parents in Ireland.
Ultimately, this strengthens children’s legal security regarding:
• parental responsibility
• inheritance
• nationality
• healthcare decision-making
• family stability
Recognition of international reality
Cross-border reproductive care has become a global reality. Patients increasingly travel abroad for:
• egg and/or sperm donor treatments
• surrogacy
• donor embryos
• fertility preservation
• treatment unavailable in their home country.
Rather than ignoring this reality, Ireland’s proposal attempts to address its legal consequences. This represents a pragmatic shift from regulating only treatments performed domestically to recognising the increasingly international nature of fertility care.
Better protection through regulation
Supporters argue that bringing these situations into a regulated legal framework offers greater protection than leaving families in prolonged legal uncertainty. Recognition procedures, judicial oversight and defined eligibility criteria may reduce disputes while safeguarding the interests of children.
The concerns raised in public debate
Despite broad support for improving legal certainty, the legislation has also attracted criticism.
Families are still waiting
One of the strongest messages emerging in Irish media has been frustration over delays. Although the principal legislation passed in 2024, many families remain unable to secure legal recognition because large sections of the Act have yet to commence. For intended parents, these delays are not simply administrative they affect everyday life, including travel, documentation and legal parenthood.
International surrogacy remains complicated
The legislation continues Ireland’s cautious approach to surrogacy. While parentage may be recognised under certain circumstances, Ireland continues to prohibit commercial surrogacy domestically and maintains strict safeguards around international arrangements.
Critics argue that many intended parents will still pursue treatment abroad, leaving Ireland responsible for resolving legal issues after the child has already been born rather than addressing the underlying causes of reproductive travel.
Equality of access
Another recurring discussion concerns equal treatment of different family structures. The briefing paper notes that previous legislation left gaps affecting some families, including same-sex male couples relying on surrogacy abroad. The proposed amendments seek to address some of these inequalities, although debate continues regarding whether they go far enough.
A broader European trend
Ireland is far from alone. Across Europe, governments are facing similar questions:
- How should children born through international surrogacy be recognised?
- Should legal parentage depend on where treatment occurred?
- Can national restrictions realistically prevent reproductive travel?
- Should legislation focus on regulating treatment or recognising families after birth?
Countries including Italy, France, Germany and Switzerland have all faced legal challenges arising from cross-border reproductive care e.g. not allowing for egg donor treatments or certain women’s access to treatments due to their civil status. Ireland’s proposed reforms therefore contribute to a much wider international discussion.
Does restrictive legislation reduce fertility treatment?
One interesting question raised indirectly by the Irish debate is whether restrictive legislation reduces assisted reproduction or merely changes where it takes place. Experience across Europe suggests that where domestic access is limited, patients increasingly travel abroad.
Cross-border reproductive care has become a well-established feature of European fertility treatment. Consequently, policymakers may increasingly need to regulate not only treatments performed within their own borders, but also the legal consequences of treatment undertaken elsewhere.
Our perspective
The Irish proposal illustrates the difficult balance every country faces.
Children deserve legal certainty.
Parents deserve clear and predictable legal recognition and clarity of parental rights.
Governments have a responsibility to establish ethical safeguards around assisted reproduction.
At the same time, legislation must recognise that fertility treatment has become increasingly international. When domestic laws and patients’ reproductive needs diverge too far, reproductive travel becomes inevitable.
The challenge for policymakers is therefore no longer simply whether assisted reproduction should be regulated, but how regulation can protect children, respect ethical principles and reflect the realities of modern family building across borders.
Ireland’s proposed Amendment Bill represents an important step towards resolving long-standing legal uncertainties. Whether it ultimately becomes a model for other countries will depend on how effectively it balances legal certainty, equality and patient-centred care.